Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors

O Juanola, S Martínez-López, R Francés… - International journal of …, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver
disease in the Western world, probably due to the growing prevalence of obesity, metabolic …

Glucokinase activators for type 2 diabetes: challenges and future developments

KA Toulis, K Nirantharakumar, C Pourzitaki, AH Barnett… - Drugs, 2020 - Springer
Increased hepatic glucose output, the primary liver dysregulation associated with Type 2
diabetes mellitus (T2DM), is not directly or effectively targeted by the currently available …

PDX1LOW MAFALOW β-cells contribute to islet function and insulin release

D Nasteska, NHF Fine, FB Ashford, F Cuozzo… - Nature …, 2021 - nature.com
Transcriptionally mature and immature β-cells co-exist within the adult islet. How such
diversity contributes to insulin release remains poorly understood. Here we show that subtle …

Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists

Y Ren, L Li, L Wan, Y Huang, S Cao - Journal of Enzyme Inhibition …, 2022 - Taylor & Francis
Type 2 diabetes mellitus is a metabolic disorder with complicated pathogenesis, and mono-
target therapy often fails to effectively manage the levels of blood glucose. In recent years …

Mitochondria-associated endoplasmic reticulum membranes allow adaptation of mitochondrial metabolism to glucose availability in the liver

P Theurey, E Tubbs, G Vial… - Journal of molecular …, 2016 - academic.oup.com
Mitochondria-associated endoplasmic reticulum membranes (MAM) play a key role in
mitochondrial dynamics and function and in hepatic insulin action. Whereas mitochondria …

Molecular and cellular regulation of human glucokinase

SM Sternisha, BG Miller - Archives of biochemistry and biophysics, 2019 - Elsevier
Glucose metabolism in humans is tightly controlled by the activity of glucokinase (GCK).
GCK is predominantly produced in the pancreas, where it catalyzes the rate-limiting step of …

[HTML][HTML] Carbotoxicity—noxious effects of carbohydrates

G Kroemer, C López-Otín, F Madeo, R de Cabo - Cell, 2018 - cell.com
Modern nutrition is often characterized by the excessive intake of different types of
carbohydrates ranging from digestible polysaccharides to refined sugars that collectively …

Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease

P Mirtschink, C Jang, Z Arany, W Krek - European heart journal, 2018 - academic.oup.com
Despite strong indications that increased consumption of added sugars correlates with
greater risks of developing cardiometabolic syndrome (CMS) and cardiovascular disease …

Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism

A Raimondo, MG Rees, AL Gloyn - Current opinion in lipidology, 2015 - journals.lww.com
GCKR variants across the allelic spectrum have effects on glucose and lipid homeostasis.
Functional analysis has highlighted numerous molecular mechanisms for GKRP …

Glucokinase (GCK) in diabetes: from molecular mechanisms to disease pathogenesis

Y Abu Aqel, A Alnesf, II Aigha, Z Islam… - Cellular & Molecular …, 2024 - Springer
Glucokinase (GCK), a key enzyme in glucose metabolism, plays a central role in glucose
sensing and insulin secretion in pancreatic β-cells, as well as glycogen synthesis in the liver …